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for this great honor. The road to revelations of the con-
cept of genomic disorders (Lupski 1998) did not always
conform to my naı¨ve preconceived notion of how it
should be, but instead our molecular findings sometimes
altered our view of genetic phenomena. The recognition
of structural features of the human genome beyond pri-
mary DNA sequence, what I have referred to as “genome
architecture,” has profound implications for how we as
a species evolved and continue to evolve, as well as ram-
ifications for common traits and human disease.
Figure 1 depicts different levels of genome architec-
ture, each of which requires distinct methodological ap-
proaches to interrogate structure and alterations thereof.
This relates to the ability to resolve the human genome
at several levels, from single base-pair changes using
DNA sequencing to the identification of chromosomal
aberration through conventional G-banded karyotypes.
Our ability to recognize genome alterations in the 104-
to 106-bp range was only enabled through the devel-
opment of techniques that could resolve genome changes
of suchmagnitude. Pulsed-field gel electrophoresis (PFGE)
(Schwartz and Cantor 1984) allowed us to separate mol-
ecules 1104 bp in size, whereas fluorescence in situ hy-
bridization (FISH) extended the reach of conventional
cytogenetics (Pinkel et al. 1986, 1988). The latter tech-
nology, of course, was the subject of the inaugural Curt
Stern Award last year, given to Dan Pinkel and Joe Gray.
The genome architecture of special interest for our work
consists of low-copy repeats that may be in a direct or
inverted orientation. Nonallelic homologous recombina-
tion (NAHR) between direct repeats results in DNA du-
plication and deletion; many such rearrangements may
be of a size that can only be assayed by FISH and/or
PFGE. Armed with these powerful technologies and a
little bit of luck, we recognized that the mechanisms for
some genetic diseases are best understood at a genomic
level when we identified a 1.5-Mb duplication associated
with the common inherited peripheral neuropathy, Char-
cot-Marie-Tooth disease type 1A (CMT1A) (Lupski et al.
1991).
However, we stumbled along the way, recognizing that
some CMT1A-linked probes gave dosage differences of
cross hybridizing bands but not initially recognizing that
this presumed artifact segregated in a Mendelian fash-
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Figure 1 Genome architecture and methods to resolve structure of varying DNA sizes. Above are shown four levels of genome architecture,
from viewing the entire human genome, resolved by conventional G-banding, to the molecular double helical structure of DNA, revealed by
x-ray crystallography. The focus of the Human Genome Project has been to determine the primary DNA sequence information. Below is shown
a scale of the human genome from 1 bp (100 bp) to bp and the size ranges (color coded) in which the different methods can physically93# 10
resolve differences. Note that the genome architecture in the size range of ∼ to bp cannot be resolved either by DNA sequencing4 63# 10 4# 10
and agarose gel electrophoresis or by conventional G-banding. The techniques of PFGE and FISH extended the range of genetic technologies,
enabling resolution of DNA rearrangements in the size range of 130 kb to !4 Mb. DNA rearrangements responsible for genomic disorders are
often within the size range resolved only by PFGE and/or FISH.
ion. The duplication forced us to rethink the interpre-
tation of marker allele segregation. When scoring as a
simple biallelic system (fig. 2), the apparent genotype of
this simple pedigree reveals an apparent recombinant.
However, duplication results in triallelic genotypes. Re-
scoring the actual genotypes as a triallelic system, after
the molecular recognition of the duplication, clearly doc-
uments that the unaffected individual does not, in fact,
represent a recombinant (fig. 2). This had profound con-
sequences for linkage analysis, with the triallelic scoring
enabling the peak LOD score to now coincide in map
position with the marker revealing molecular duplica-
tion (fig. 2).
The CMT1A duplication was actually visualized by
multiple molecular methods (Patel and Lupski 1994),
including FISH, PFGE, and dosage differences of het-
erozygous alleles for restriction-fragment–length poly-
morphisms (RFLPs), but it was the three alleles observed
in affected individuals by short-tandem repeat (STR) or
microsatellite analysis that first illuminated the molec-
ular duplication for us. The cosegregation of the disease
with a junction fragment measuring 500 kb and resolved
by PFGE suggested a stable mutation and a precise
recombination mechanism (Lupski et al. 1991). These
findings, in combination with observations fromVincent
Timmerman in Christine van Broeckhoven’s group that
marker genotypes which revealed the de novo duplica-
tion were accompanied by unequal crossing-over, sug-
gested that there might be repeated sequences flanking
the genomic segment that was duplicated. Indeed, Pen-
tao Liu in my laboratory identified the repeat, which
was 120 kb in size and highly homologous, that we
termed “CMT1A-REP.” As predicted by the unequal
crossing-over model, CMT1A-REP was found to be pre-
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Figure 2 The effects of molecular duplication on the interpretation of marker genotypes and linkage mapping. Standard pedigree symbols
are used: females depicted by circles and males by squares. Filled-in symbols denote affected individuals. On the left is a simple pedigree with
marker genotypes scored as a usual biallelic system with one of the two alleles inherited from each parent. One unaffected daughter is an
apparent recombinant, since she has the same apparent genotype as her three affected siblings. To the right is shown the actual genotypes scored
as a triallelic system, accounting for the molecular duplication. The lower right shows how the different scoring biallelic (dashed line) versus
triallelic (bold line) affects the multipoint LOD score. Note the differences in peak LOD scores and the fact that the failure to account for three
alleles (or dosage differences in heterozygous RFLPs) results in an erroneous map position.
sent in three copies on the CMT1A duplication–bearing
chromosome (Pentao et al. 1992) and one copy in the
reciprocal deletion responsible for a clinically milder ep-
isodic neuropathy known as hereditary neuropathy with
liability to pressure palsies (HNPP) (Chance et al. 1994;
Reiter et al. 1996). However, what was completely sur-
prising was that the CMT1A-REP repeat, as well as the
later-identified SMS-REP repeat responsible for the Smith-
Magenis syndrome (SMS) (Chen et al. 1997) and its du-
plication reciprocal (Potocki et al. 2000), were not present
in lower mammals, including mouse and hamster.
Another interesting observation from Southern anal-
yses was that the two identified different size cross-hy-
bridizing fragments do not represent polymorphic al-
leles, as both are present in the monochromosomal 17
hybrid MH22-6 (Pentao et al. 1992). I must digress now
to differentiate variation of allelic sequences on different
chromosome homologues, or polymorphisms, from var-
iation in low-copy repeat (LCR) sequences on the same
chromosomes—a phenomenon we have termed cis-
morphisms (fig. 3) (Boerkoel et al. 1999). This is of
particular interest, given the recent excitement about sin-
gle-nucleotide polymorphisms (SNPs). If 10% or more
of the human genome consists of LCRs, are 10% of
SNPs actually cis-morphisms? What are the implications
for mapping complex traits using SNPs? I draw your
attention to an excellent recent paper by Xavier Estivill,
Lap-Chee Tsui, and colleagues that appeared in Human
Molecular Genetics. This paper documents that a sig-
nificant proportion of the SNPs in the NCBI database
correspond to paralogous sequence variants (PSVs) that
could represent either cis-morphisms or trans-morph-
isms (fig. 3) within segmental duplications (LCRs) of the
human genome sequence (Estivill et al. 2002).
Let’s return to the evolution of low-copy repeats. Since
no CMT1A-REP copies were identified in mouse and
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Figure 3 Paralagous sequence variations (PSVs). Above are depicted homologous chromosomes (thin horizontal lines), with centromeres
(white circles) to the right. LCR sequences (white rectangles) are shown with sequence variations depicted as colored letters. The white x, y,
and z denote unique flanking sequences in the genome used to anchor BAC clones (horizontal red lines). Below is shown a hypothetical Southern
analysis with lanes containing genomic DNA and DNA from BAC clones. Cis-morphisms refer to paralogous sequence variations on the same
chromosome B/b (yellow). Trans-morphisms (C/c) refer to PSVs on different chromosomes. Both cis-morphisms and trans-morphisms are revealed
by BAC-specific cross-hybridizing restriction endonuclease fragment bands when using an LCR-specific probe. These PSVs are distinguished
from polymorphisms (A/a; purple), the latter referring to allelic variation of the same sequence on different chromosome homologues. It is not
clear what percentage of SNPs are actually paralogous sequence variants. Nor is it immediately obvious how the lack of recognition of this
distinction (i.e., SNP vs. PSV) may effect the interpretation of mapping and other genetic studies. Potentially, the lack of this distinction in
mapping studies could have one or more of three effects (since the PSVs can be several megabases apart or even on different chromosomes):
erroneous map position, loss of linkage, or false positive linkage.
hamster, after determining that CMT1A-REP represents
segmental duplication of a portion of the COX10 gene
encoding hemeA:farnesyltransferase (Murakami et al.
1997; Reiter et al. 1997), we and others performed ge-
nomic Southern and cis-morphism analyses in closely
related primate species (Reiter et al. 1997; Boerkoel et
al. 1999). Remarkably, CMT1A-REP is duplicated in
human and chimpanzee but not in gorilla, orangutan,
or another 1 dozen closely related primate species (Ki-
yosawa and Chance 1996; Reiter et al. 1997; Keller et
al. 1999)! Of even greater interest, by comparing human
and mouse genomic and EST databases, the segmental
duplication of CMT1A-REP resulted in the creation of
two new genes with completely different expression pro-
files (Inoue et al. 2001; Inoue and Lupski 2002). Studies
of the derivation of a number of LCRs reveal that each
of them evolved relatively recently and predominately
during primate speciation (reviewed in Samonte and Ei-
chler 2002; Stankiewicz and Lupski 2002b). Thus, as
the human genome evolves, we appear to accumulate
LCRs through segmental duplication (Bailey et al. 2002).
These LCRs create a genome architecture likely impor-
tant to ongoing genome evolution and make us partic-
ularly vulnerable to genomic disorders (Emanuel and
Shaikh 2001; Stankiewicz and Lupski 2002a). LCRs
may also be involved in karyotypic evolution during
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Figure 4 Evolution of proximal 17p LCR during primate speciation. Proximal chromosome 17p is depicted by two thin horizontal lines
with the centromere (white circle) shown to the right. LCRs are shown as horizontal rectangles with the same color or black-and-white graphic,
representing highly homologous (identity usually 197%) sequence. Above are shown the genomic segments (orange), either duplicated in CMT1A
and dup(17)(p11.2p11.2) or deleted in HNPP and SMS, respectively. To the right is shown a time line of mammalian, mainly primate, speciation,
with the millions of years (Mya) as indicated. The white numbers circled in black indicate the approximate time at which the segmental
duplication occurred and the given LCR appeared. The depicted sequence of events represents a working model that most parsimoniously
explains present experimental observations. Note that one of the oldest LCRs, LCR17pA (1), was split by the most recent segmental duplication
(8) that resulted in the proximal CMT1A-REP, which is present in humans and chimpanzees. Likewise, the proximal SMS-REP (3) has split a
more ancient LCR (2) into LCR17pC and LCR17pD. The present orientation of middle SMS-REP and LCR17pB in the human genome may
result from an inversion event after a directly oriented copy of middle SMS-REP appeared during primate speciation through a segmental
duplication of proximal SMS-REP (6). The vertical dotted yellow line demarcates the evolutionary chromosome translocation 4;19 in Gorilla
gorilla (7). Incredibly, LCRs represent 123% of the 7.4-Mb genomic sequence analyzed in proximal 17p. The majority of these LCRs have
been found at the breakpoint of at least one DNA rearrangement.
primate speciation (Stankiewicz et al. 2001). Recently,
utilizing a human genome diversity cell-line panel (Cann
et al. 2002) and CMT1A-REP probes, we have obtained
evidence suggesting that these LCRs are continuing to
evolve and may vary among selected world populations.
We also identified similar experimental findings of a
common, recurrent rearrangement, as evidenced by a spe-
cific junction fragment detected by PFGE, in the Smith-
Magenis contiguous gene syndrome (SMS) (Chen et al.
1997). A hint for a recurrent rearrangement was ob-
tained several years earlier, when the same genetic mark-
ers were shown to be deleted for the majority of SMS
patients, suggesting clustering of breakpoints (Greenberg
et al. 1991). The SMS deletion and reciprocal duplica-
tion rearrangements are mediated through a large LCR,
termed “SMS-REP,” that represents a repeat gene cluster
(Chen et al. 1997). We used cis-morphisms within SMS-
REPs to position large insert BAC clones for genomic
sequencing. The nucleotide-sequence analysis revealed
complex structure sharing 1160 kb of 98% sequence
identity among the three SMS-REP copies (Park et al.
2002). These SMS-REP sequences are not present in the
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mouse, as documented by direct genomic sequence com-
parisons (Bi et al. 2002). Interestingly, portions of SMS-
REPs are also repeated elsewhere on chromosome 17.
FISH analysis of metaphase chromosome 17 reveals the
multiple cross-hybridizing signals and higher order ar-
chitecture of SMS-REP–like sequences throughout chro-
mosome 17 (Park et al. 2002).
For the medical geneticist, a FISH test using only two
probes can detect multiple rearrangements within prox-
imal 17p responsible for genomic disorders. These in-
clude the CMT1A duplication, the HNPP deletion, and
the SMS del(17)(p11.2p11.2) and its reciprocal dup(17)
(p11.2p11.2). Incredibly, using this assay, we identified
a patient with DNA rearrangements on both homo-
logues of chromosome 17 whose phenotype consisted of
mild delay and a family history of autosomal dominant
carpal tunnel syndrome (Potocki et al. 1999). The oc-
currence of both the 17p11.2 duplication and the HNPP
deletion in this patient likely reflects the relatively high
frequency at which these abnormalities arise and the
underlying molecular characteristics of the genome in
this region.
Our recent efforts have focused on studying the break-
points of patients with uncommon rearrangements in
proximal 17p. The majority of these breakpoints (∼60%)
also occurred in LCRs and actually enabled the identi-
fication of yet more LCRs (Park et al. 2002). In fact, at
least 23% of genome sequences within proximal 17p are
contained within LCRs. FISH studies using primate cell
lines in conjunction with molecular clock analysis ena-
bled a working model that most parsimoniously explains
how higher-order genomic architecture in proximal 17p
evolved through a series of consecutive segmental du-
plications during primate speciation (fig. 4). Note that
the most recent event is the segmental duplication of
distal CMT1A-REP to result in proximal CMT1A-REP.
In summary, molecular studies of the CMT1A dupli-
cation, the SMS deletion, their reciprocal recombination
products, and other rearrangements that cause genomic
disorders have revealed general features regarding the
mechanisms for these disorders. First, it is clear that these
rearrangements are not random events but rather reflect
genome architecture. This genome architecture consists
of region-specific LCRs that contribute to the suscepti-
bility to DNA rearrangement. Furthermore, LCRs pro-
vide substrates for NAHR or unequal crossing-over.
Thus, genomic disorders are recombination-based dis-
eases and not resultant from errors in DNA replication/
repair. The LCRs appear to have arisen recently during
primate speciation through segmental duplication and
likely play a role in genome evolution. The human ge-
nome has evolved an architecture that may make us as
a species more susceptible to rearrangements causing ge-
nomic disorders. Finally, genomic disorders contribute
in a significant way to disease burden.
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